Sarepta Therapeutics, Inc. - 8-K Filing

Sarepta settles patent litigation with REGENXBIO and UPenn for $39M. (Items: 1.01 Entry into a Material Definitive Agreement)

SEC EDGAR ·

Tickers: $SRPT

Read the full article at SEC EDGAR

More Regulatory news